Jaguar Health (JAGX) Shares Outstanding (2020 - 2026)
Jaguar Health's (JAGX) quarterly Shares Outstanding (Entity) came in at $439.0 in Q4 2023, up 1656.0% year-on-year from $25.0 in Q4 2022, and up 11.14% on a QoQ basis from $395.0 in Q3 2023.
Jaguar Health (JAGX) Shares Outstanding (2020 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 3 years of Shares Outstanding (Entity) data on file, last reported at $439.0 in Q4 2023.
- On a quarterly basis, Shares Outstanding (Entity) rose 1656.0% year-over-year to $439.0 in Q4 2023; TTM through Dec 2023 was $439.0, a 1656.0% increase from a year earlier, with the FY2023 full-year figure at $439.0, up 1656.0% from the prior year.
- Shares Outstanding (Entity) for Q4 2023 stood at $439.0, up from $395.0 in the prior quarter.
- Over the last five years, Shares Outstanding (Entity) for JAGX reached as high as $439.0 in Q4 2023 and fell as low as $11.0 in Q1 2021.
- Historically, Shares Outstanding (Entity) has averaged $116.25 across 3 years, with a median of $22.5 in 2022.
- Across the five-year window, Shares Outstanding (Entity) changed 0.0% in 2022 and jumped 1656.0% in 2023, its largest moves.
- Year by year, Shares Outstanding (Entity) stood at $11.0 in 2021, then jumped by 127.27% to $25.0 in 2022, then soared by 1656.0% to $439.0 in 2023.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $439.0 in Q4 2023, $395.0 in Q3 2023, and $336.0 in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | 47.82 Bn |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | 118.76 Bn |
| 3 | BeOne Medicines | 473.37 Bn | 468.58 Bn | 1.35 Bn | 1.44 Bn |
| 4 | Vertex Pharmaceuticals | 123.58 Bn | 116.33 Bn | 2.59 Bn | 254.10 Mn |
| 5 | Regeneron Pharmaceuticals | 71.54 Bn | 62.78 Bn | 3.31 Bn | 104.00 Mn |
| 6 | Belite Bio | 62.17 Bn | 62.17 Bn | - | 400.00 Mn |
| 7 | Argenx Se | 54.63 Bn | 49.44 Bn | 1.41 Bn | 62.19 Mn |
| 8 | Alnylam Pharmaceuticals | 38.11 Bn | 35.10 Bn | 959.66 Mn | 132.89 Mn |
| 9 | Revolution Medicines | 36.17 Bn | 36.17 Bn | - | 198.10 Mn |
| 10 | Jaguar Health | 523,524.81 | -9.54 Mn | 19.11 Mn | 515,788.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515,788.00 |
| Dec 31, 2025 | 66,640.00 |
| Sep 30, 2025 | 43,234.00 |
| Jun 30, 2025 | 28,994.00 |
| Mar 31, 2025 | 17,904.00 |
| Dec 31, 2024 | 8,415.00 |
| Sep 30, 2024 | 10,709.00 |
| Jun 30, 2024 | 2,685.00 |
| Mar 31, 2024 | 3,026.00 |
| Dec 31, 2023 | 439.00 |
| Sep 30, 2023 | 395.00 |
| Jun 30, 2023 | 336.00 |
| Mar 31, 2023 | 97.00 |
| Dec 31, 2022 | 25.00 |
| Sep 30, 2022 | 27.00 |
| Jun 30, 2022 | 20.00 |
| Mar 31, 2022 | 11.00 |
| Dec 31, 2021 | 11.00 |
| Sep 30, 2021 | 12.00 |
| Jun 30, 2021 | 11.00 |